Latest From AlzProtect SAS
Can crowdfunding fill the biotech capital gap? In the US, new services are jockeying at the starting gate even though the government’s final rules won’t be ready soon, while in Europe the experiment has begun in earnest.
- Therapeutic Areas
- Neurology, Nervous System
- Western Europe
- Parent & Subsidiaries
- AlzProtect SAS
- Senior Management
- Philippe Verwaerde, PhD, Pres., CEO & CSO
- Contact Info
Phone: (33) 320 29088 61
Batiment Biserte, 1 Place de Verdun
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.